Jean-Pierre Soulier

from Wikipedia, the free encyclopedia

Jean-Pierre Soulier (born September 14, 1915 in Étretat , † January 18, 2003 in Paris ) was a French hematologist .

Life

Jean-Pierre Soulier was born in 1915 in a small village in Normandy. He was the grandson of a surgeon. After attending elementary and high school in Rouen , at the age of 15 he moved to the “Pasteur” high school in the Neuilly district of Paris, where he obtained his university entrance qualification. He then completed a medical degree at the University of Paris, which he graduated in 1937. Further training took him to Harvard University in the United States for a year as a research fellow in 1945 . On his return he was first head of the laboratory of a regional blood donation service in Paris. Nine years later he was appointed director of the National Institute for Transfusion Service . In 1961 he was appointed professor of hematology at the University of Paris. From 1978 to 1980 he was President of the International Society for Transfusion Medicine.

plant

The main interests of his research were both in the field of blood transfusion and blood clotting . He introduced some techniques to study various problems in this area. In 1947 he published the discovery of the anticoagulant substance phenylindanedione and the first preparation of a therapeutic blood plasma fraction for the successful treatment of a factor IX and prothrombin complex deficiency. The Bernard-Soulier syndrome , a congenital disorder of the functions of the blood platelets ( thrombocytes ) with an increased tendency to bleed, was named after him.

Web links